The oxycodone drugs market, while essential for pain management, operates within a complex landscape due to the high potential for abuse and addiction associated with this opioid. Valued at USD 5.19 billion in 2023, the market is projected to reach USD 8.29 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period. This growth must be viewed in the context of ongoing efforts to address the opioid crisis.
Some of the major players operating in the global market include:
- Acura Pharmaceuticals (U.S.)
- Alvogen (U.S.)
- Amneal Pharmaceuticals LLC. (U.S.)
- Ascent Pharmaceuticals, Inc. (U.S.)
- Collegium Pharmaceutical (U.S.)
- Endo International plc (Ireland)
- Epic Pharma, LLC. (U.S.)
- Mallinckrodt (Ireland)
- Mundipharma International (UK)
- Pfizer Inc. (U.S.)
- Protega Pharmaceuticals Inc. (U.S.)
- Rhodes Pharmaceuticals L.P. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
Market Overview:
Oxycodone is a semi-synthetic opioid analgesic prescribed for the management of moderate to severe pain. It is available in both immediate-release (IR) and extended-release (ER) formulations. This market is heavily regulated due to the drug’s high potential for abuse and addiction.
Key Drivers of Market Growth:
- Increasing Prevalence of Chronic Pain: The rising prevalence of chronic pain conditions, such as arthritis, back pain, and cancer pain, is driving the demand for effective pain management solutions, including opioids like oxycodone.
- Post-Surgical Pain Management: Oxycodone is often used for managing acute pain following surgical procedures. The increasing number of surgical procedures performed globally contributes to the market.
Recent Developments:
- Protega Pharmaceuticals’ RoxyBond Launch: The introduction of RoxyBond, an immediate-release oxycodone, highlights the ongoing need for pain management options. The development of abuse-deterrent formulations is a key trend in the opioid market, although not specifically mentioned for RoxyBond.
- Clinical Trial at Ningxia Medical University: This clinical trial investigating oxycodone for post-surgical bladder discomfort highlights the ongoing research into new applications for this drug and the exploration of its use in managing different types of pain.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
Oxycodone Drugs Market, Drug Type Outlook (Revenue – USD Billion, 2019-2032)
- Short-acting
- Long-acting
Oxycodone Drugs Market, Dosage Form Outlook (Revenue – USD Billion, 2019-2032)
- Tablet
- Capsule
- Injection
Oxycodone Drugs Market, Distribution Channel Outlook (Revenue – USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Market Trends:
- Abuse-Deterrent Formulations: The development and adoption of abuse-deterrent formulations (ADFs) of oxycodone and other opioids are increasing. ADFs are designed to make it more difficult to crush, snort, or inject the drug, reducing the potential for misuse.
- Focus on Non-Opioid Pain Management: There is a growing emphasis on non-opioid pain management strategies, such as physical therapy, cognitive behavioral therapy, and non-opioid medications, to reduce reliance on opioids and mitigate the risk of addiction.
- Stricter Regulations: Governments and regulatory agencies are implementing stricter regulations on the prescribing and dispensing of opioids to combat the opioid crisis.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/oxycodone-drugs-market
Market Opportunities:
- Emerging Markets: The increasing access to healthcare in emerging markets presents growth opportunities for the oxycodone drugs market, particularly in regions where pain management options are limited.
- Novel Drug Delivery Systems: The development of novel drug delivery systems, such as transdermal patches or implantable pumps, could improve the safety and efficacy of oxycodone and other opioids.
Challenges:
- Opioid Crisis: The ongoing opioid crisis, characterized by widespread addiction and overdose deaths, poses a significant challenge to the oxycodone drugs market.
- Abuse and Addiction: Oxycodone has a high potential for abuse and addiction, requiring careful prescribing and monitoring by healthcare providers.
- Strict Regulatory Environment: The highly regulated environment surrounding opioids can be challenging for pharmaceutical companies operating in this market.
Table of Contents:
- Global Oxycodone Drugs Market Insights
4.1. Oxycodone Drugs Market – Distribution Channel Snapshot
4.2. Oxycodone Drugs Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising incidence of chronic pain is expected to support the oxycodone market expansion
4.2.1.2. Increasing expenses for oxycodone drugs will provide a long-term opportunity for the market growth
4.2.2. Restraints and Challenges
4.2.2.1. Several risks of oxycodone coupled with strict regulations is expected to hamper the market growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Oxycodone Drugs Market Distribution Channel Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Oxycodone Drugs Market, by Drug Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Oxycodone Drugs Market, by Drug Type, 2019-2032 (USD Billion)
5.3. Short-acting
5.3.1. Global Oxycodone Drugs Market, by Short-acting, by Region, 2019-2032 (USD Billion)
5.4. Long-acting
5.4.1. Global Oxycodone Drugs Market, by Long-acting, by Region, 2019-2032 (USD Billion)
6. Global Oxycodone Drugs Market, by Dosage Form
6.1. Key Findings
6.2. Introduction
6.2.1. Global Oxycodone Drugs Market, by Dosage Form, 2019-2032 (USD Billion)
6.3. Tablet
6.3.1. Global Oxycodone Drugs Market, by Tablet, by Region, 2019-2032 (USD Billion)
6.4. Capsule
6.4.1. Global Oxycodone Drugs Market, by Capsule, by Region, 2019-2032 (USD Billion)
6.5. Injection
6.5.1. Global Oxycodone Drugs Market, by Injection, by Region, 2019-2032 (USD Billion)
Conclusion:
The oxycodone drugs market faces a delicate balancing act. While the drug plays a crucial role in managing pain, the risks associated with its use, particularly the potential for abuse and addiction, cannot be ignored. The market’s future will depend on the development and adoption of safer formulations, stricter regulations, and a greater emphasis on non-opioid pain management strategies. Ongoing research into new applications and delivery methods will also play a role in shaping the market’s trajectory. Ultimately, addressing the opioid crisis will require a multi-faceted approach involving healthcare providers, policymakers, and communities.
More Trending Latest Reports By Polaris Market Research:
Electronic Thermal Management Materials Market